These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15230902)

  • 1. In reference to "Botox in dermatology" by Abbas Khawaja and Hernández-Pérez.
    Hernandez-Perez E
    Int J Dermatol; 2004 Jul; 43(7):550. PubMed ID: 15230902
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the patient for cosmetic Botox injections.
    Dayan SH; Bassichis BA
    Facial Plast Surg Clin North Am; 2003 Aug; 11(3):349-58. PubMed ID: 15062263
    [No Abstract]   [Full Text] [Related]  

  • 3. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?
    Johns Hopkins Med Lett Health After 50; 2001 Mar; 13(1):8. PubMed ID: 11232481
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of Botox to treat glabellar rhytids.
    Bassichis BA; Thomas JR
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):453-6. PubMed ID: 15062249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine].
    Sommer B; Bergfeld D; Sattler G
    J Dtsch Dermatol Ges; 2007 Feb; 5 Suppl 1():S1-S29. PubMed ID: 17229195
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
    Balikian RV; Zimbler MS
    Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevant anatomy for botulinum toxin facial rejuvenation.
    Loos BM; Maas CS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):439-43. PubMed ID: 15062247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of botulinum toxin type A in the upper face.
    Carruthers J; Carruthers A
    Facial Plast Surg Clin North Am; 2006 Aug; 14(3):253-60. PubMed ID: 16908393
    [No Abstract]   [Full Text] [Related]  

  • 10. Cosmetic treatments and strategies for the upper face.
    Frankel AS; Markarian A
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):31-9, vi. PubMed ID: 17317553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment?
    Hsu TS; Dover JS; Kaminer MS; Arndt KA; Tan MH
    Arch Dermatol; 2003 Jul; 139(7):948. PubMed ID: 12873906
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the optimum dose of type a botulinum toxin for treating neurogenic bladder overactivity?
    Shah J; Patki P; Patil K; Wood S
    BJU Int; 2006 Aug; 98(2):466-7. PubMed ID: 16879701
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM; Gladstone HB
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments and corrections on the REAL DOSE study.
    Kingswell RS; Caird D
    Mov Disord; 2006 Apr; 21(4):582-3; author reply 583-4. PubMed ID: 16511854
    [No Abstract]   [Full Text] [Related]  

  • 16. Botox reverses the signs of photoaging.
    Sadick NS;
    J Drugs Dermatol; 2003 Dec; 2(6):683-6. PubMed ID: 14711152
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis.
    Rystedt A; Swartling C; Färnstrand C; Naver H
    Acta Derm Venereol; 2008; 88(5):458-61. PubMed ID: 18779882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of Botox by iontophoresis.
    Solomon P
    Br J Dermatol; 2005 Nov; 153(5):1075; author reply 1076. PubMed ID: 16225634
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.